Efficacy of NEPA, a novel combination of netupitant (NETU) and palonosetron (PALO), for prevention of chemotherapy-induced nausea and vomiting (CINV) following highly emetogenic chemotherapy (HEC).
Paul Joseph Hesketh
Consultant or Advisory Role - Helsinn Therapeutics
Honoraria - Helsinn Therapeutics
Giorgia Rossi
Employment or Leadership Position - Helsinn Therapeutics
Giada Rizzi
Employment or Leadership Position - Helsinn Therapeutics
Marco Palmas
Employment or Leadership Position - Helsinn Therapeutics
Anna Alyasova
No relevant relationships to disclose
Igor Drobner
No relevant relationships to disclose
Richard J. Gralla
Consultant or Advisory Role - Helsinn Therapeutics
Honoraria - Helsinn Therapeutics